#123 - Joan Mannick, M.D. & Nir Barzilai, M.D.: Rapamycin and metformin—longevity, immune enhancement, and COVID-19

The Peter Attia Drive

Peter Attia, MD

Health & Fitness, Medicine, Fitness

4.7 • 7.3K Ratings

🗓️ 10 August 2020

⏱️ 138 minutes

🔗️ Recording | iTunes | RSS

🧾️ Download transcript

Summary

In this episode, Joan and Nir discuss their extensive research into rapamycin (including the category of analogs to rapamycin known as rapalogs) and metformin, respectively. Based on his work with metformin, Nir shares how he believes it could be a pro-longevity drug and the clinical trial he’s leading to test this belief. Joan discusses her work with rapalogs, their ability to suppress the immune system as well as provide immune-enhancement, and the clinical trials she has led that inform her insights. We also talk about the potential beneficial roles of both metformin and rapamycin in reducing mortality from COVID-19, reducing the risk of neurodegenerative diseases, and delaying aging as well as its related diseases.

We discuss:

Joan’s career, interest in aging, and work with rapamycin analogs [3:45];
When Nir became convinced metformin could be a pro-longevity agent [15:00];
How metformin and rapamycin impact the hallmarks of aging and extend lifespan [24:15];
Enhancing the immune system with rapalogs and metformin [34:15];
Potential of metformin and rapamycin in reducing mortality from COVID-19 [41:30];
Insights from Joan’s studies investigating the immune-enhancing effects of rapalogs [59:30];
Vaccines and treatments strategies for COVID-19, and the likelihood of long-term immunity [1:08:15];
The potential role of rapalogs and metformin in neurodegenerative disease [1:14:30];
Nir’s TAME trial—primary objectives and latest updates [1:18:00];
Potential synergistic effect when combining metformin with rapamycin [1:25:45];
Why Peter stopped taking metformin and started taking rapamycin [1:27:30];
Story from Nir’s book that demonstrates the challenge of doing good scientific studies [1:37:30];
The biology of aging—epigenetic clocks, proteomics, and Nir’s centenarian data [1:42:00];
Joan’s dream experiment to test immune-enhancing effect of RTB101 [1:57:15];
Concluding thoughts on COVID-19 [1:59:45]; and
More.

Learn more: https://peterattiamd.com/

Show notes page for this episode: http://peterattiamd.com/joanmannick-nirbarzilai/

Subscribe to receive exclusive subscriber-only content: https://peterattiamd.com/subscribe/

Sign up to receive Peter's email newsletter: https://peterattiamd.com/newsletter/

Connect with Peter on Facebook | Twitter | Instagram.

Transcript

Click on a timestamp to play from that location

0:00.0	Hey everyone, welcome to the Drive Podcast.
0:13.0	I'm your host, Peter Atia.
0:14.8	This podcast, my website, and my weekly newsletter, all focus on the goal of translating
0:18.7	the science of longevity into something accessible for everyone.
0:22.4	Our goal is to provide the best content in health and wellness, full stop, and we've
0:26.6	assembled a great team of analysts to make this happen.
0:29.4	If you enjoy this podcast, we've created a membership program that brings you far more
0:33.2	in-depth content if you want to take your knowledge of this space to the next level.
0:37.2	At the end of this episode, I'll explain what those benefits are, or if you want to learn
0:41.0	more now, head over to peteratiamd.com forward slash subscribe.
0:46.2	Now, without further delay, here's today's episode.
0:51.1	My guests this week are doctors Joan Manek and Near Parzly.
0:56.4	Joan is the co-founder and chief medical officer of Restore Bio, and that's a play on the
1:01.4	word tour, T-O-R, target of Rapa Mison.
1:05.6	Before joining Restore Bio, she was the executive director in the New Indications Discovery
1:10.5	Unit of Novartis, which we discussed early on in this podcast.
1:15.0	She is an MD by training, receiving her MD from Harvard Medical School, completing her
1:18.5	residency in internal medicine and infectious diseases at the Brigham and Women's Hospital.
1:24.0	Peter Parzly is making his second appearance on the podcast, so that name may sound familiar
1:28.0	to a number of you.
1:29.8	He is the director of the Institute for Aging Research at Albert Einstein College of Medicine
1:35.6	in New York.
	...

Please login to see the full transcript.

Previous episode | Next episode

Disclaimer: The podcast and artwork embedded on this page are from Peter Attia, MD, and are the property of its owner and not affiliated with or endorsed by Tapesearch.

Generated transcripts are the property of Peter Attia, MD and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.